Publication | Closed Access
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
514
Citations
18
References
2015
Year
Merck & Co.
| Year | Citations | |
|---|---|---|
Page 1
Page 1